Fairclough Michael, Prenant Christian, Brown Gavin, McMahon Adam, Lowe Jonathan, Jones Anthony
Wolfson Molecular Imaging Centre, The University of Manchester, 27 Palatine Road, Manchester, M20 3LJ, UK.
J Labelled Comp Radiopharm. 2014 May 15;57(5):388-96. doi: 10.1002/jlcr.3194. Epub 2014 Apr 1.
[6-O-Methyl-(11)C]diprenorphine ([(11)C]diprenorphine) is a positron emission tomography ligand used to probe the endogenous opioid system in vivo. Diprenorphine acts as an antagonist at all of the opioid receptor subtypes, that is, μ (mu), κ (kappa) and δ (delta). The radiosynthesis of [(11)C]diprenorphine using [(11)C]methyl iodide produced via the 'wet' method on a home-built automated radiosynthesis set-up has been described previously. Here, we describe a modified synthetic method to [(11)C]diprenorphine performed using [(11)C]methyl iodide produced via the gas phase method on a GE TRACERlab FXFE radiochemistry module. Also described is the use of [(11)C]methyl triflate as the carbon-11 methylating agent for the [(11)C]diprenorphine syntheses. [(11)C]Diprenorphine was produced to good manufacturing practice standards for use in a clinical setting. In comparison to previously reported [(11)C]diprenorphine radiosyntheisis, the method described herein gives a higher specific activity product which is advantageous for receptor occupancy studies. The radiochemical purity of [(11)C]diprenorphine is similar to what has been reported previously, although the radiochemical yield produced in the method described herein is reduced, an issue that is inherent in the gas phase radiosynthesis of [(11)C]methyl iodide. The yields of [(11)C]diprenorphine are nonetheless sufficient for clinical research applications. Other advantages of the method described herein are an improvement to both reproducibility and reliability of the production as well as simplification of the purification and formulation steps. We suggest that our automated radiochemistry route to [(11)C]diprenorphine should be the method of choice for routine [(11)C]diprenorphine productions for positron emission tomography studies, and the production process could easily be transferred to other radiochemistry modules such as the TRACERlab FX C pro.
[6-O-甲基-(11)C]二丙诺啡([(11)C]二丙诺啡)是一种正电子发射断层扫描配体,用于在体内探测内源性阿片系统。二丙诺啡对所有阿片受体亚型,即μ(μ)、κ(κ)和δ(δ)受体均起拮抗剂作用。此前已描述了在自制的自动化放射性合成装置上通过“湿”法使用[(11)C]甲基碘进行[(11)C]二丙诺啡的放射性合成。在此,我们描述了一种在GE TRACERlab FXFE放射化学模块上使用气相法制备的[(11)C]甲基碘进行[(11)C]二丙诺啡合成的改进方法。还描述了使用[(11)C]三氟甲磺酸甲酯作为[(11)C]二丙诺啡合成的碳-11甲基化剂。[(11)C]二丙诺啡按照良好生产规范标准制备,用于临床。与先前报道的[(11)C]二丙诺啡放射性合成相比,本文所述方法得到的产物比活更高,这对受体占有率研究有利。[(11)C]二丙诺啡的放射化学纯度与先前报道的相似,尽管本文所述方法的放射化学产率有所降低,这是[(11)C]甲基碘气相放射性合成中固有的问题。然而,[(11)C]二丙诺啡的产率足以满足临床研究应用。本文所述方法的其他优点包括提高了生产的重现性和可靠性,以及简化了纯化和制剂步骤。我们建议,我们的[(11)C]二丙诺啡自动化放射化学路线应是正电子发射断层扫描研究中常规[(11)C]二丙诺啡生产的首选方法,并且该生产过程可轻松转移至其他放射化学模块,如TRACERlab FX C pro。